Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Ann Oncol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    November 2022
  1. BAZINET A, Kantarjian HM
    Moving towards individualized target-based therapies in acute myeloid leukemia.
    Ann Oncol. 2022 Nov 21:S0923-7534(22)04734-2. doi: 10.1016/j.annonc.2022.
    PubMed     Abstract available


    April 2022
  2. GEYER CE, Sikov WM, Loibl S
    Reply to the Letter to the Editor "Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple negative breast cancer" by A. Okines and N. Turner.
    Ann Oncol. 2022 Apr 4. pii: S0923-7534(22)00671.
    PubMed    


    March 2022
  3. OKINES A, Turner N
    Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple negative breast cancer.
    Ann Oncol. 2022 Mar 14. pii: S0923-7534(22)00364.
    PubMed    


    November 2021
  4. VAN GELDER M, Tournilhac O, Te Raa D, Visser HPJ, et al
    Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL.
    Ann Oncol. 2021;32:1442-1443.
    PubMed    


    August 2021
  5. LORIOT Y, Marabelle A, Guegan JP, Danlos FX, et al
    Plasma proteomics identifies Leukemia Inhibitory Factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance.
    Ann Oncol. 2021 Aug 17. pii: S0923-7534(21)03978.
    PubMed     Abstract available


    May 2021
  6. DONNETTE M, Ciccolini J, Pissier C, Costello R, et al
    High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications.
    Ann Oncol. 2021;32:684-686.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: